Avastin

Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin

Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin

Bloomberg

Fake Avastin may not be the only counterfeit on doctors' shelves

Fake Avastin may not be the only counterfeit on doctors' shelves

Fierce Pharma

EU OKs Roche's Avastin for ovarian cancer

EU OKs Roche's Avastin for ovarian cancer

Reuters

New Setback for Avastin as Breast Cancer Treatment

New Setback for Avastin as Breast Cancer Treatment

NY Times, NY

CEO: Roche would consider more money-back deals

CEO: Roche would consider more money-back deals

Fierce Pharma

Winners and Losers of Roche's Avastin Woes

Winners and Losers of Roche's Avastin Woes

Motley Fool

Joining FDA, Canada pulls Avastin's breast cancer indication

Joining FDA, Canada pulls Avastin's breast cancer indication

Fierce Pharma

F.D.A. Revokes Approval of Avastin as Breast Cancer Drug

F.D.A. Revokes Approval of Avastin as Breast Cancer Drug

NY Times, NY

VA Reinstates Avastin Usage For Eye Disease

VA Reinstates Avastin Usage For Eye Disease

Pharmalot

Roche Unit Didn't Follow Procedures To Prevent Drug Contamination; Galena Presents Positive NeuVax Clinical Results

Roche Unit Didn't Follow Procedures To Prevent Drug Contamination; Galena Presents Positive NeuVax Clinical Results

Biomed Reports